Anthem Biosciences IPO: A Deep Dive into Last-Day Surge
Anthem Biosciences IPO saw robust demand, closing 4x subscribed. Explore the GMP, institutional interest, and what happens after bidding, all explained in a casual chat.
Anthem Biosciences IPO saw robust demand, closing 4x subscribed. Explore the GMP, institutional interest, and what happens after bidding, all explained in a casual chat.
Integrity Infrabuild Developers IPO opens on May 13 at ₹100/share. Don’t miss this infrastructure investment opportunity.
